Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

 

Recent News and Articles on the Keywords: 72,100 + web + 0.30  Related to the article below (Last Update: 8/4/2008)

Puget Energy Reports Second Quarter 2008 Financial Results
WELT ONLINE, Germany -
11, 2008, a copy of which will be available through the SEC?s Web site at www.sec.gov or at www.pugetenergy.com. Investors are encouraged to read the ...PSD
Source: Google News

[PDF] ASIA-P
NP Diameters, W Spiral, PMMM Mannesmann-Pilger, … - portal.mustangeng.com
... Products Division, Structual & Pipeline Products, Industrial Hwy., Mayfield, NSW
2530, Australia; Phone: 61 49 411 711; Fax: 61 49 411 705; Web Site: www ...
-

Genotypic variation in tetraploid wheat affecting homoeologous pairing in hybrids with Aegilops … -
H Ozkan, M Feldman - Genome, 2001 - article.pubs.nrc-cnrc.gc.ca
... Published on the NRC Research Press Web site at http ... Sciences, The Weizmann Institute
of Science, Rehovot 72100, Israel ... 3.05 (0?6) 0.30 (0?1) __ 3.73 (0?11 ...

[PDF] The Potential Demand for an HIV/AIDS Vaccine in Brazil -
EJA Luna - www-wds.worldbank.org
... Policy Research Working Papers are also posted on the Web at http://econ.worldbank.
org. Hillegonda Maria Dutilh Novaes may be contacted at hidutilh@usp.br. ...

User?s Guide -
AR Cowan - eventstudy.com
... Please visit our Web site, www.eventstudy.com, for additional usage ex ... 72100 19970626
75111 19980209 77142 981016 36150 19970616 77170 19981118 75241 19980805 ...
-

LTO N -
MS Khan, MRA Al-Mandhary, MK Al-Suti, N Feeder, S … - J. Chem. Soc., Dalton Trans, 2002 - rsc.org
... 4AD Received 20th November 2001, Accepted 15th January 2002 First published
as an Advance Article on the web 26th February 2002 ...
-

[CITATION] User?s Guide
CD Retrieval
-

CONTROL AGENTS FOR LIVING-TYPE FREE RADICAL POLYMERIZATION, METHODS OF POLYMERIZING, EMULSIONS AND … -
D Charmot, HT Chang, Y LI, P Huefner - EP Patent 1,322,674, 2006 - freepatentsonline.com
... Some of the log P values in this application were estimated from the web site
http://esc.syrres.com/interkow/kowdemo.htm, which provides an estimated log P ...
-

Ethylene polymers having enhanced processability -
GN Foster, T Chen, SH Wasserman, DC Lee, SJ Kurtz, … - US Patent 5,798,427, 1998 - freepatentsonline.com
... suffering from melt fracture, overheating, or web instability problems ... 0.56 91.76
0.9231 13 Invention 0.30 118.00 0.9200 ... 89669 4.97 1.11 0.7 20300 72100 3.55 19 ...

[BOOK] Adopting Medicare Fee Schedules: Considerations for the California Workers' Compensation Program -
BO Wynn - 2003 - books.google.com
... 451-6979 Email: Robert_Reville@rand.org A profile of the ICJ, abstracts of its
publications, and ordering information can be found on the World Wide Web at http ...

Magnetic and other properties of iron-aluminum alloys melted in vacuo -
TD Yensen, WA Gatward - ideals.uiuc.edu
... 46360 58600 64400 84800 88700 62000 72100 77700 83300 ... 6000 870 1880 8400 13300 0.30
0.35 Iron ... of Reinforced Concrete Beams: Resistance to Web Stresses, Series ...

Source: Google Scholar
 
 

Glaxo adds strong heart risk warning to ADHD drug

 
 

WASHINGTON - GlaxoSmithKline Plc has said it will add a strong warning about possible heart risk to its attention deficit hyperactivity drug Dexedrine, according to a letter posted on the U.S. Food and Drug Administration's Web site on Monday.

Packaging for the drug will also include information about possible psychiatric adverse events, like hallucinations and mania, linked to stimulants, according to the letter dated August 4.

Inclusion of the new warning comes after two FDA advisory panels offered conflicting opinions over how strong such warnings should be.

FDA representatives could not be immediately reached for comment.

In March, an FDA panel said new information about heart risks should be added to the labels for attention deficit drugs. The outside experts stopped short of supporting a "black box" warning -- the strongest warning possible -- saying they did not want to scare off patients or their parents.

The panel also said ADHD drug labels should include information about possible psychiatric risks.

In February, a different FDA panel recommended black box warnings.

In its letter, Glaxo said it was adding the warning "in response to a Food and Drug Administration ... request sent to the manufacturers of all CNS (central nervous system) stimulant products approved for the treatment of ADHD."

The British drugmaker said its drug will caution patients and doctors that "misuse of amphetamines may cause sudden death and serious cardiovascular adverse events."

Dexedrine will also include warnings about the risk of sudden death, hypertension and other concerns associated with stimulant treatment in children and adolescents who have heart problems.

Shares of Glaxo were up 6 cents, or well under 1 percent, at $54.50 in afternoon trade on the New York Stock Exchange.

Copyright © 2006 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

 
 
 
Google
Web www.iconocast.com
 
 
 

 

Continue News With: News9A ;

 

ALL THE NEWS : News1 ; News2 ; News3 ; News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 © 2002-2006

Keywords::

Contact Iconocast

Home Page